Rio Ferdinand backs DNAFit

09 May 2018

By: Sport Industry Group

DNAFit has confirmed the appointment of new shareholder, Rio Ferdinand, as head advisor of its health, wellness and sports advisory board.

The role will see the former England international footballer join forces with the consumer genetics brand, as part of a shared mission to improve the nation’s health via a greater understanding of how DNA impacts our wellbeing,

The new partnership, which also sees Ferdinand take a "significant" undisclosed investment stake within the genetics brand, kicks off a period of aggressive growth for DNAFit, according to the brand. 

In his new role, Rio will work with DNAFit on a number of initiatives within local and national communities, to support using genetics for preventative health purposes. These will focus on the use of genetics to help individuals make better health and diet choices through understanding their unique personal responses to a range of markers such as carbohydrates and fats, as well as predispositions to health risks such as cancers.

He will also draw on his insight and expertise from his playing career to work alongside DNAFit sports science experts on a range of projects and studies within elite sport. 

DNAFit is a wellness genetics company who match both elite sportspeople and ordinary consumers to the fitness and diet plans that best match their DNA. Since 2013 they have helped more than 50,000 people make decisions around their wellness and nutrition regardless of their personal goal, ranging from the occasional gymgoer to Olympic athletes such as Greg Rutherford.

Ferdinand said: "I’m extremely excited to be joining the team at DNAFit to help our nation discover the potential of personalised wellness through the use of our genetics. As a sportsman, I can identify with how this unique genetically driven approach can be a bridge to enhance training outcomes and performance. But more than anything, I want to help people live healthier, happier lives.

“As you know, my own family has suffered huge personal losses to diseases such as cancer, which has motivated me to search for how we can educate ourselves around preventative health. I see my investment into DNAFit as an investment into the future of UK health.”

Avi Lasarow, CEO of DNAFit, added: “After meeting Rio, it quickly became clear that our missions are truly aligned. In seeking to change the world of preventative health, we will use genetics to empower people with valuable information that puts them in control of their health.

“As such we are delighted to welcome Rio as a strategic investor and as Head Advisor of the DNAFit Health, Wellness and Sports Advisory Board. Rio’s passion in this space is contagious, and he will be a vital part of a new advisory team that will create a pathway to make a significant impact in the health of millions.”